- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04241250
Neuromodulation Techniques After SCI
Transspinal Versus Epidural Stimulation for Exoskeletal Assisted Walking After Spinal Cord Injury
Study Overview
Status
Conditions
Detailed Description
Restoring locomotion following spinal cord injury (SCI) has been the focus of years of research aimed at ameliorating several of health-related comorbidities. Spinal cord epidural stimulation (SCES) exhibits the rehabilitation potential of restoring locomotion in individuals with SCI when combined with intensive locomotion training. Despite this potential, such protocols are likely impractical when applied across large clinical SCI populations due to high monetary costs. Similar to SCES, transspinal stimulation (TS) has also exhibited neuromodulatory benefits by externally stimulating lumbro-sacral neural circuity to generate step-like activities in persons with complete SCI; however, these techniques also require intense gait training. Recently robotic exoskeletons have been used as a promising tool to circumvent limitations associated with labor-intensive locomotor training, and have been safely used as an effective approach in improving levels of physical activity in persons with complete SCI.
Recent work has demonstrated the benefits of combining EAW and neuromodulatory techniques. Following 12-weeks of EAW+SCES training, improvements in locomotion led researchers to decrease the amount of EAW swing assistance to 35% in a person with a C7 complete SCI. This was accompanied by 573 unassisted steps, which represents 50% of the total number of steps taken during that session. Electromyographic (EMG) activity also increased during both stance and swing phases, reflecting the individual's ability to rhythmically fire paralyzed muscles during EAW+SCES. Additionally, cardio-metabolic loads were increased during exoskeletal stepping when combined with SCES as compared to stepping without SCES. The participant also showed a modest decrease in his total and regional absolute fat mass. These preliminary findings suggest that neuromodulation using SCES with exoskeletal ambulation may provide a feasible rehabilitation approach for persons with SCI. The goal of the current study is to examine and compare the effects of EAW combined with SCES or TS in persons with motor complete SCI. The data generated from this application will also enable larger clinal trials to explore ways to optimize exoskeletal assisted gait training through the use of different neuromodulation modalities with SCI.
Following a repeated-measure design, 10 participants with chronic, motor complete (AIS A and B) SCI (age:18-60 years) will be randomly assigned to participate in either 6-months of EAW+SCES (n=5) or EAW+TS (n=5) training. The entire duration of the trial will be approximately 1 year for each participant. Initially, participants will undergo 3-months of EAW training (3 sessions/week), which will be followed by randomization into either a EAW+SCES group or EAW+TS group for an additional 6-months of training (both groups: 3 sessions/week) and a 3-month follow-up period for both groups. Measurements at baseline (BL: prior to EAW) and 4 post-intervention timepoints will occur every 3-months (P1: following 3-months of EAW; P2: following 3-months of EAW+TS or EAW+SCES; P3: after completing 6-months of EAW+TS or EAW+SCES; P4: 3-months after termination of EAW+TS or EAW+SCES).
This pilot work will have 3 specific aims: Aim 1. The investigators will determine and compare improvements to locomotor control following 6 months of EAW+TS and EAW+SCES as measured by 10-meter walking speed, the number of unassisted EAW steps, and EMG activity.
Aim 2. The investigators will determine and compare improvements to cardio-metabolic risk factors following 6 months of EAW+TS and EAW+SCES as measured by total and regional body composition, oxygen uptake, and fasting lipid profile.
Aim 3. The investigators will determine and compare improvements in bladder health following 6 months of EAW+TS and EAW+SCES as measured by bladder filling and emptying
Study Type
Enrollment (Estimated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Ashraf Gorgey, PhD PT
- Phone Number: 3386 (804) 675-5000
- Email: ashraf.gorgey@va.gov
Study Contact Backup
- Name: Robert Trainer, MD
- Phone Number: (804) 675-5110
- Email: robert.trainer@va.gov
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23249-0001
- Recruiting
- Hunter Holmes McGuire VA Medical Center, Richmond, VA
-
Contact:
- William F Maragos, MD PhD
- Phone Number: 804-675-5127
- Email: William.Maragos@va.gov
-
Contact:
- Robert C Dresch
- Phone Number: (804) 675-5151
- Email: robert.dresch@va.gov
-
Principal Investigator:
- Ashraf Gorgey, PhD PT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All participants will be between 18-70 years old, male, with traumatic motor complete SCI and level of injury of T10 and above, as determined by EMG testing and International Standards for Neurological Classification of SCI (ISNCSCI) exam
- All participants will undergo ISNCSCI examination for neurological level and function and only those with American Spinal Injury Classification (AIS A and B; i.e. motor deficit below the level of injury) will be included
Exclusion Criteria:
Participants with any of the following pre-existing medical conditions will be excluded from the current trial:
- Diagnosis of neurological injury other than SCI, including cauda equina or distal conus injuries resulting in limb or sacral areflexia
- Unhealed fracture in either lower or upper extremities
- Severe scoliosis, hip knee range of motion (ROM) or flexion knee contractures preventing positioning in an exoskeleton or plantarflexion contracture greater than 20 degrees
- Untreated or uncontrolled hypertension defined as high resting blood pressure greater than 140/90 mmHg and severe orthostatic hypotension (drop greater than 20 mmHg compared to resting supine blood pressure) or incapable to maintain a sitting or EAW standing posture
- Other medical conditions including cardiovascular disease, uncontrolled type II DM, uncontrolled hypertension, and those on insulin, pressures sores stage 3 or greater, or symptomatic urinary tract infection
- Unable to fit in the device for any reason
- Taking anti-coagulants or anti-platelet agents, including aspirin if unable to be off this medication for medical reasons
- Implanted pacemakers and/or implanted defibrillator devices
- DXA T-Score less than -2.5. Scans done will include total body, dual hips and knees. Total hip BMD T-scores < -3.5 and knee BMD scores of less than 0.6 g/cm2
Functional upper and lower extremity ROM, strength, spasticity and skin integrity will also have assessed prior to enrollment in the program.
The Modified Ashworth Scale will be used to ensure safety of the participants prior to engagement in the rehabilitation program
- Participants with severe spasticity or limited ROM will be excluded from the trial
- This is based on the Ekso manufacturer's recommendations
- Untreatable severe spasticity judged to be contraindicated by the site Physician
- Pressure ulcer of the trunk, pelvic area, or lower extremities of grade 3 or more
- Psychopathology documentation in the medical record or history that may conflict with study objectives
- Any condition that, in the judgment of the principal investigator or medical provider, precludes safe participation in the study and/or increases the risk of infection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: EAW+SCES
Three months of exoskeleton training followed by 6 months of epidural stimulation.
|
Three months of exoskeleton training followed by 6 months of epidural stimulation.
|
Experimental: EAW+TS
Three months of exoskeleton training followed by 6 months of transspinal stimulation.
|
Three months of exoskeleton training followed by 6 months of transspinal stimulation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
10-meter walking speed (m/sec)
Time Frame: 9 months
|
After fitted in the robotic exoskeleton, the participant will be asked to walk for 10-meter distance and the time and speed will be determined.
|
9 months
|
Muscles electromyography (EMG) activity (micro-volts)
Time Frame: 9 months
|
EMG activity will measure electrical activity from 12 leg muscles of hip, knee, and ankle joints during locomotion
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fat mass and fat-free mass (kg)
Time Frame: 9 months
|
Body composition will be captured using dual energy x-ray absorptiometry (DXA) to measure fat mass (kg) and fat-free mass (kg) every 3 months during the course of the trial.
|
9 months
|
Oxygen Uptake (ml/min)
Time Frame: 9 months
|
Oxygen uptake during resting, standing and walking will be measured during 6 minutes walking test every 3 months during the course of the trial.
|
9 months
|
Fasting lipid profile (mg/dl)
Time Frame: 9 months
|
After overnight fast, blood will be drawn to measure your circulating triglycerides, low and high density lipoproteins and cholesterol.
|
9 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Volume of bladder Capacity during filling and voiding (ml)
Time Frame: 9 months
|
A multichannel urodynamics system (Laborie) will be used to perform urodynamic studies .
A urethral catheter will be placed, and saline is infused into the bladder.
A pressure transducer is also inserted into the bladder and records pressure during filling.
We will then measure the volume of the bladder during filling and during emptying.
|
9 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Ashraf Gorgey, PhD PT, Hunter Holmes McGuire VA Medical Center, Richmond, VA
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B3456-P
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injury
-
Taipei Veterans General Hospital, TaiwanThe Industrial Technology Research InstituteUnknownSpinal Cord Injuries | Complete Spinal Cord Injury | Incomplete Spinal Cord InjuryTaiwan
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingSCI - Spinal Cord Injury | Incomplete Spinal Cord InjuryUnited States
-
Jill M. Wecht, Ed.D.Icahn School of Medicine at Mount SinaiRecruitingBlood Pressure | Spinal Cord Injuries | SCI - Spinal Cord Injury | Blood Pressure Disorders | Traumatic Spinal Cord Injury | Acute Spinal Cord Injury | Neuromodulation | Spinal Cord StimulationUnited States
-
NervGen PharmaRecruitingSpinal Cord Injuries | Chronic Spinal Cord Injury | Subacute Spinal Cord InjuryUnited States
-
MetroHealth Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS); Case Western...RecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Spinal Cord Injury CervicalUnited States
-
Kevin KilgoreNational Institute of Neurological Disorders and Stroke (NINDS); Case Western... and other collaboratorsRecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Spinal Cord Injury Cervical | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C5-C7 Level With Incomplete LesionUnited States
-
The University of Texas Health Science Center,...TerminatedSpinal Cord Injuries | Cervical Spinal Cord Injury | Traumatic Spinal Cord CompressionUnited States
-
StemCells, Inc.TerminatedStudy of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord InjuryCervical Spinal Cord Injury | Spine Injury | Cervical Spine InjuryUnited States, Canada
-
S.Biomedics Co., Ltd.Yonsei University; Linical Co., Ltd.RecruitingSpinal Cord Injury, Acute | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C4 Level With Complete LesionKorea, Republic of
-
Mahidol UniversityRecruitingSpinal Cord Injury | Incomplete Spinal Cord InjuryThailand
Clinical Trials on EAW+SCES (exoskelton and spinal cord epidural stimulation)
-
University of LouisvilleUniversity of California, Los Angeles; National Institute for Biomedical Imaging... and other collaboratorsCompleted
-
Susan Harkema PhDThe Leona M. and Harry B. Helmsley Charitable TrustActive, not recruitingSpinal Cord InjuriesUnited States
-
University of CalgaryInternational Collaboration on Repair DiscoveriesUnknownSpinal Cord Injuries | Autonomic Dysreflexia | Orthostatic Hypotension, DysautonomicCanada
-
University of MinnesotaRecruitingSCI - Spinal Cord InjuryUnited States
-
The Methodist Hospital Research InstituteNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingSpinal Cord Injuries | NeuromodulationUnited States
-
University of MinnesotaMinneapolis Veterans Affairs Medical Center; Hennepin Healthcare Research Institute and other collaboratorsRecruitingSpinal Cord Injuries | Paraplegia, CompleteUnited States
-
Mayo ClinicMinnesota Office of Higher EducationTerminatedParaplegia, Spinal | Paraplegia, Complete | Paraplegia; TraumaticUnited States
-
University of Alabama at BirminghamRecruitingHypertension | Low Back Pain | Blood PressureUnited States
-
University of LouisvilleNational Heart, Lung, and Blood Institute (NHLBI)RecruitingRehabilitation | Spinal Cord Injuries | Breathing Exercises | Spinal Cord StimulationUnited States
-
Rhode Island HospitalBrown University; US Department of Veterans Affairs; Boston Scientific Corporation and other collaboratorsRecruiting